181 related articles for article (PubMed ID: 36091937)
1. Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature.
Hino C; Pham B; Gray AL; Wang J; Castillo DR; Akhtari M; Liu Y
Pathol Oncol Res; 2022; 28():1610588. PubMed ID: 36091937
[TBL] [Abstract][Full Text] [Related]
2. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
Zapata M; Budnick SD; Bordoni R; Li S
Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
4. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.
Sriganeshan V; Blom TR; Weissmann DJ
Arch Pathol Lab Med; 2008 Aug; 132(8):1346-9. PubMed ID: 18684040
[TBL] [Abstract][Full Text] [Related]
5. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
[TBL] [Abstract][Full Text] [Related]
6. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma with aberrant expression of CD10.
Zanetto U; Dong H; Huang Y; Zhang K; Narbaitz M; Sapia S; Kostopoulos I; Liu H; Du MQ; Bacon CM
Histopathology; 2008 Jul; 53(1):20-9. PubMed ID: 18518902
[TBL] [Abstract][Full Text] [Related]
8. BCL6, MUM1, and CD10 expression in mantle cell lymphoma.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):103-8. PubMed ID: 19826251
[TBL] [Abstract][Full Text] [Related]
9. B-cell lymphomas with coexpression of CD5 and CD10.
Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
11. A possible new morphological variant of mantle cell lymphoma with plasma-cell type Castleman disease-like features.
Igawa T; Omote R; Sato H; Taniguchi K; Miyatani K; Yoshino T; Sato Y
Pathol Res Pract; 2017 Nov; 213(11):1378-1383. PubMed ID: 28974340
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous blastoid mantle cell lymphoma-case report.
Estrozi B; Sanches JA; Varela PC; Bacchi CE
Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
[TBL] [Abstract][Full Text] [Related]
13. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
14. A unique case of blastoid variant of mantle cell lymphoma with an aberrant CD5-/CD10+/Bcl-6+/CD56+ immunophenotype: a case report.
Park S; Ko YH
Tumori; 2012; 98(4):e111-4. PubMed ID: 23052175
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
de Leon ED; Alkan S; Huang JC; Hsi ED
Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
[TBL] [Abstract][Full Text] [Related]
16. Blastic mantle cell lymphoma with a Burkitt translocation.
Reddy K; Ansari-Lari M; Dipasquale B
Leuk Lymphoma; 2008 Apr; 49(4):740-50. PubMed ID: 18398742
[TBL] [Abstract][Full Text] [Related]
17. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
18. CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.
Akhter A; Mahe E; Street L; Pournazari P; Perizzolo M; Shabani-Rad MT; Stewart DA; Mansoor A
J Clin Pathol; 2015 Oct; 68(10):844-8. PubMed ID: 26124315
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review.
Castillo DR; Park D; Jeon WJ; Joung B; Lee J; Yang C; Pham B; Hino C; Chong E; Shields A; Nguyen A; Brothers J; Liu Y; Zhang KK; Cao H
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
